Abstract:ABSTRACT A randomized, two-way, crossover study was conducted in 18 healthy male Chinese volunteers to compare pharmacokinetics profiles of galantamine hydrobromide dispersible tablet with that of conventional tablet. A single oral dose of 10 mg galantamine was administrated to each volunteer. Plasma concentrations of galantamine were determined by a validated high-performance liquid chromatography (HPLC) method with fluorescence detection, which allowed 1 ng/mL to be assayed as the lowest quantifiable concentration. From plasma concentrations, AUC0→t (the area under the plasma concentration-time curve from time 0 to the last sampling time, 32 hr), AUC0→∞ (the area under the plasma concentration-time curve from time 0 to infinity), t½ (elimination of half-life of the terminal log linear phase), Cmax (maximum plasma drug concentration) and Tmax (time to reach Cmax) were evaluated through noncompartmental pharmacokinetic analysis. AUC0→t and AUC0→∞ were calculated by the linear-log trapezoidal rule method. Cmax and Tmax were obtained directly from the plasma concentration-time curve. Analysis of variance was carried out using logarithmically transformed AUC0→t, AUC0→∞ and Cmax. As far as AUC0→t, AUC0→∞ and Cmax were concerned, there was no statistically significant difference between the test and reference formulations. Ninety percent confidence intervals (90% CI) for the ratio of AUC0→t, AUC0→∞ and Cmax values for the test and reference formulations were 100.4–107.8%, 99.0–107.2% and 87.5–111.3%, respectively. As the 90% CIs of AUC0→t, AUC0→∞ and Cmax were entirely within 80–125%, two formulations were considered bioequivalent.

Pharmacokinetics and Bioequivalence of Rebamipide Dispersible Tablets in Healthy Volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

HPLC assay for determination of rebamipide in plasma and its pharmacokinetic investigation

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Evaluation of Bioequivalence of Mirtazapine Tablets

Study on Bioequivalence of Risperidone Tablets

Pharmacokinetics and Bioequivalance of Ambroxol Dispersible Tablets in Healthy Volunteers

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence and Pharmacokinetics of Zolpidem Tartrate Mouth-dissolving Tablets

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Bioequivalence of Imported and Domestic Risperidone Film-Coated Tablets in Healthy Volunteers

Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability

A high velocity impact device for obtaining multiple, contiguous, myocardial biopsies.

Evaluation of the Bioequivalence and Pharmacokinetics of Two Formulations of Rizatriptan after Single Oral Administration in Healthy Volunteers

Studies on the bioequivalence of two sodium rebeprazole entric tablets in healthy volunteers

Pharmacokinetics and Bioequivalence Studies of Galantamine Hydrobromide Dispersible Tablet in Healthy Male Chinese Volunteers

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Pharmacokinetics and Bioequivalence Study of Cefixime Tablet in Healthy Volunteers

Pharmacokinetics and bioequivalence of domestic and imported ramipril tablets